US Drug Recall Register
Class III · Low risk Terminated Initiated Jun 13, 2018 (8 years ago)

Equate ClearLAX

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Not Elsewhere Classified - A private label distributor noted unfiled NDC numbers on EQ ClearLax Polyethylene Glycol 3350 NF Powder Solution of various sizes.

What was recalled

Equate ClearLAX, Polyethylene Glycol 3350 Powder for Solution, OS Osmotic Laxative, OTC, packaged in a) 119 g bottle (NDC 49035-312-07), b) 238 g bottle (NDC 49035-312-08), Distributed by: Wal-mart Stores, Inc., Bentonville, AR 72716

Recalling firm
Lupin Somerset
NDC code
49035-312-07
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0907-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Polyethylene recalls

See all
Class II · Moderate risk Ongoing

Artificial Tears Lubricant Eye Drops

Reason Lack of Assurance of Sterility

Preferred Pharmaceuticals, Inc. NDC 68788-7266-0 D-0443-2026
Class II · Moderate risk Ongoing

Sterile Eye Drops Soothing Tears

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 0536-1219-94 D-0415-2026
Class II · Moderate risk Ongoing

Ultra Lubricating Eye Drops

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 70000-0457-1 D-0412-2026
Class II · Moderate risk Ongoing

Dry Eye Relief Eye Drops

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 57896-181-05 D-0411-2026
Class II · Moderate risk Ongoing

EYE DROPS Advanced Relief

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 83324-191-14 D-0410-2026